HEADER TRANSCRIPTION 24-DEC-22 8HUL TITLE X-RAY STRUCTURE OF HUMAN PPAR DELTA LIGAND BINDING DOMAIN-LANIFIBRANOR TITLE 2 CO-CRYSTALS OBTAINED BY CO-CRYSTALLIZATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPAR-DELTA,NUCI,NUCLEAR HORMONE RECEPTOR 1,NUC1,NUCLEAR COMPND 5 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2,PEROXISOME PROLIFERATOR- COMPND 6 ACTIVATED RECEPTOR BETA,PPAR-BETA; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARD, NR1C2, PPARB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.KAMATA,A.HONDA,Y.MACHIDA,K.UCHII,Y.SHIIYAMA,R.MASUDA,T.OYAMA, AUTHOR 2 I.ISHII REVDAT 2 06-SEP-23 8HUL 1 JRNL REVDAT 1 09-AUG-23 8HUL 0 JRNL AUTH S.KAMATA,A.HONDA,R.ISHIKAWA,M.AKAHANE,A.FUJITA,C.KANEKO, JRNL AUTH 2 S.MIYAWAKI,Y.HABU,Y.SHIIYAMA,K.UCHII,Y.MACHIDA,T.OYAMA, JRNL AUTH 3 I.ISHII JRNL TITL FUNCTIONAL AND STRUCTURAL INSIGHTS INTO THE HUMAN PPAR ALPHA JRNL TITL 2 / DELTA / GAMMA TARGETING PREFERENCES OF ANTI-NASH JRNL TITL 3 INVESTIGATIONAL DRUGS, LANIFIBRANOR, SELADELPAR, AND JRNL TITL 4 ELAFIBRANOR. JRNL REF ANTIOXIDANTS V. 12 2023 JRNL REFN ESSN 2076-3921 JRNL PMID 37627519 JRNL DOI 10.3390/ANTIOX12081523 REMARK 2 REMARK 2 RESOLUTION. 2.46 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1-2575-000 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.46 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.81 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.930 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.5 REMARK 3 NUMBER OF REFLECTIONS : 25149 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.770 REMARK 3 FREE R VALUE TEST SET COUNT : 2163 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.8050 - 6.0631 0.95 2984 192 0.1671 0.1859 REMARK 3 2 6.0631 - 4.8153 0.93 2988 131 0.2049 0.2150 REMARK 3 3 4.8153 - 4.2075 0.93 2958 170 0.1777 0.2262 REMARK 3 4 4.2075 - 3.8231 0.92 2914 154 0.1817 0.1950 REMARK 3 5 3.8231 - 3.5493 0.92 2903 151 0.1996 0.2502 REMARK 3 6 3.5493 - 3.3402 0.92 2987 134 0.2222 0.2790 REMARK 3 7 3.3402 - 3.1730 0.91 2908 155 0.2204 0.2657 REMARK 3 8 3.1730 - 3.0349 0.89 2807 132 0.2421 0.2659 REMARK 3 9 3.0349 - 2.9181 0.88 2862 152 0.2474 0.2584 REMARK 3 10 2.9181 - 2.8175 0.89 2777 138 0.2489 0.2944 REMARK 3 11 2.8175 - 2.7294 0.89 2848 146 0.2396 0.2685 REMARK 3 12 2.7294 - 2.6514 0.89 2854 124 0.2541 0.3132 REMARK 3 13 2.6514 - 2.5816 0.89 2821 120 0.2634 0.3067 REMARK 3 14 2.5816 - 2.5186 0.89 2879 133 0.2703 0.3796 REMARK 3 15 2.5186 - 2.4614 0.87 2714 131 0.2952 0.3865 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.26 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4306 REMARK 3 ANGLE : 0.447 5826 REMARK 3 CHIRALITY : 0.034 657 REMARK 3 PLANARITY : 0.002 728 REMARK 3 DIHEDRAL : 15.609 2590 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HUL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1300031704. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUN-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25193 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.460 REMARK 200 RESOLUTION RANGE LOW (A) : 48.020 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.46 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.16 REMARK 200 STARTING MODEL: 7WGL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M BIS-TRIS PROPANE (PH 8.0), 14% REMARK 280 PEG8000, 0.1 M KSCN, 6% PROPANEDIOL, 0.001 M EDTA, 0.001 M CACL2, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.47400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 166 REMARK 465 SER A 167 REMARK 465 HIS A 168 REMARK 465 MET A 169 REMARK 465 PRO A 170 REMARK 465 GLN A 171 REMARK 465 VAL A 172 REMARK 465 ALA A 173 REMARK 465 ALA A 205 REMARK 465 SER A 206 REMARK 465 HIS A 207 REMARK 465 THR A 208 REMARK 465 LYS A 229 REMARK 465 GLN A 230 REMARK 465 LEU A 231 REMARK 465 VAL A 232 REMARK 465 ASN A 233 REMARK 465 GLY A 234 REMARK 465 TYR A 441 REMARK 465 GLY B 166 REMARK 465 SER B 167 REMARK 465 HIS B 168 REMARK 465 MET B 169 REMARK 465 PRO B 170 REMARK 465 GLN B 171 REMARK 465 VAL B 172 REMARK 465 LYS B 204 REMARK 465 ALA B 205 REMARK 465 SER B 206 REMARK 465 HIS B 207 REMARK 465 THR B 208 REMARK 465 LYS B 229 REMARK 465 GLN B 230 REMARK 465 LEU B 231 REMARK 465 VAL B 232 REMARK 465 ASN B 233 REMARK 465 GLY B 234 REMARK 465 TYR B 441 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 204 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 227 -49.10 -133.55 REMARK 500 LYS A 239 -57.50 -136.92 REMARK 500 ALA A 306 75.85 51.91 REMARK 500 ASN A 307 29.01 47.73 REMARK 500 ASP A 360 32.49 -97.36 REMARK 500 ASN A 366 73.12 -106.14 REMARK 500 GLU A 424 57.34 -108.04 REMARK 500 ASP B 174 -65.16 69.95 REMARK 500 VAL B 227 -49.98 -143.41 REMARK 500 LYS B 239 -61.40 -127.95 REMARK 500 ASN B 366 75.54 -105.68 REMARK 500 GLU B 424 66.20 -111.48 REMARK 500 ASP B 439 80.69 48.54 REMARK 500 REMARK 500 REMARK: NULL DBREF 8HUL A 170 441 UNP Q03181 PPARD_HUMAN 170 441 DBREF 8HUL B 170 441 UNP Q03181 PPARD_HUMAN 170 441 SEQADV 8HUL GLY A 166 UNP Q03181 EXPRESSION TAG SEQADV 8HUL SER A 167 UNP Q03181 EXPRESSION TAG SEQADV 8HUL HIS A 168 UNP Q03181 EXPRESSION TAG SEQADV 8HUL MET A 169 UNP Q03181 EXPRESSION TAG SEQADV 8HUL GLY B 166 UNP Q03181 EXPRESSION TAG SEQADV 8HUL SER B 167 UNP Q03181 EXPRESSION TAG SEQADV 8HUL HIS B 168 UNP Q03181 EXPRESSION TAG SEQADV 8HUL MET B 169 UNP Q03181 EXPRESSION TAG SEQRES 1 A 276 GLY SER HIS MET PRO GLN VAL ALA ASP LEU LYS ALA PHE SEQRES 2 A 276 SER LYS HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN SEQRES 3 A 276 MET THR LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS SEQRES 4 A 276 ALA SER HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU SEQRES 5 A 276 THR LEU TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN SEQRES 6 A 276 LEU VAL ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL SEQRES 7 A 276 HIS VAL PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR SEQRES 8 A 276 VAL ARG GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER SEQRES 9 A 276 PHE SER SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU SEQRES 10 A 276 LYS TYR GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SEQRES 11 A 276 SER ILE VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SEQRES 12 A 276 SER GLY PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG SEQRES 13 A 276 LYS PRO PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE SEQRES 14 A 276 ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP SEQRES 15 A 276 LEU ALA LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP SEQRES 16 A 276 ARG PRO GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE SEQRES 17 A 276 GLN ASP THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN SEQRES 18 A 276 ALA ASN HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU SEQRES 19 A 276 LEU GLN LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU SEQRES 20 A 276 HIS ALA GLN MET MET GLN ARG ILE LYS LYS THR GLU THR SEQRES 21 A 276 GLU THR SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS SEQRES 22 A 276 ASP MET TYR SEQRES 1 B 276 GLY SER HIS MET PRO GLN VAL ALA ASP LEU LYS ALA PHE SEQRES 2 B 276 SER LYS HIS ILE TYR ASN ALA TYR LEU LYS ASN PHE ASN SEQRES 3 B 276 MET THR LYS LYS LYS ALA ARG SER ILE LEU THR GLY LYS SEQRES 4 B 276 ALA SER HIS THR ALA PRO PHE VAL ILE HIS ASP ILE GLU SEQRES 5 B 276 THR LEU TRP GLN ALA GLU LYS GLY LEU VAL TRP LYS GLN SEQRES 6 B 276 LEU VAL ASN GLY LEU PRO PRO TYR LYS GLU ILE SER VAL SEQRES 7 B 276 HIS VAL PHE TYR ARG CYS GLN CYS THR THR VAL GLU THR SEQRES 8 B 276 VAL ARG GLU LEU THR GLU PHE ALA LYS SER ILE PRO SER SEQRES 9 B 276 PHE SER SER LEU PHE LEU ASN ASP GLN VAL THR LEU LEU SEQRES 10 B 276 LYS TYR GLY VAL HIS GLU ALA ILE PHE ALA MET LEU ALA SEQRES 11 B 276 SER ILE VAL ASN LYS ASP GLY LEU LEU VAL ALA ASN GLY SEQRES 12 B 276 SER GLY PHE VAL THR ARG GLU PHE LEU ARG SER LEU ARG SEQRES 13 B 276 LYS PRO PHE SER ASP ILE ILE GLU PRO LYS PHE GLU PHE SEQRES 14 B 276 ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP SEQRES 15 B 276 LEU ALA LEU PHE ILE ALA ALA ILE ILE LEU CYS GLY ASP SEQRES 16 B 276 ARG PRO GLY LEU MET ASN VAL PRO ARG VAL GLU ALA ILE SEQRES 17 B 276 GLN ASP THR ILE LEU ARG ALA LEU GLU PHE HIS LEU GLN SEQRES 18 B 276 ALA ASN HIS PRO ASP ALA GLN TYR LEU PHE PRO LYS LEU SEQRES 19 B 276 LEU GLN LYS MET ALA ASP LEU ARG GLN LEU VAL THR GLU SEQRES 20 B 276 HIS ALA GLN MET MET GLN ARG ILE LYS LYS THR GLU THR SEQRES 21 B 276 GLU THR SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS SEQRES 22 B 276 ASP MET TYR HET BJB A 501 42 HET BJB B 501 42 HETNAM BJB 4-[1-(1,3-BENZOTHIAZOL-6-YLSULFONYL)-5-CHLORO-INDOL-2- HETNAM 2 BJB YL]BUTANOIC ACID FORMUL 3 BJB 2(C19 H15 CL N2 O4 S2) HELIX 1 AA1 ASP A 174 PHE A 190 1 17 HELIX 2 AA2 THR A 193 GLY A 203 1 11 HELIX 3 AA3 ASP A 215 GLY A 225 1 11 HELIX 4 AA4 GLU A 240 SER A 266 1 27 HELIX 5 AA5 ILE A 267 LEU A 273 1 7 HELIX 6 AA6 PHE A 274 ALA A 295 1 22 HELIX 7 AA7 ARG A 314 SER A 319 1 6 HELIX 8 AA8 PHE A 324 LEU A 341 1 18 HELIX 9 AA9 ASP A 344 LEU A 357 1 14 HELIX 10 AB1 ASN A 366 HIS A 389 1 24 HELIX 11 AB2 TYR A 394 GLU A 424 1 31 HELIX 12 AB3 HIS A 430 LYS A 438 1 9 HELIX 13 AB4 ASP B 174 PHE B 190 1 17 HELIX 14 AB5 THR B 193 LEU B 201 1 9 HELIX 15 AB6 ASP B 215 LYS B 224 1 10 HELIX 16 AB7 GLU B 240 SER B 266 1 27 HELIX 17 AB8 ILE B 267 LEU B 273 1 7 HELIX 18 AB9 PHE B 274 ALA B 295 1 22 HELIX 19 AC1 ARG B 314 SER B 319 1 6 HELIX 20 AC2 PRO B 323 ILE B 327 5 5 HELIX 21 AC3 ILE B 328 ALA B 340 1 13 HELIX 22 AC4 ASP B 344 LEU B 357 1 14 HELIX 23 AC5 ASN B 366 HIS B 389 1 24 HELIX 24 AC6 TYR B 394 GLU B 424 1 31 HELIX 25 AC7 HIS B 430 LYS B 438 1 9 SHEET 1 AA1 4 PHE A 211 ILE A 213 0 SHEET 2 AA1 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 AA1 4 GLY A 302 VAL A 305 -1 N VAL A 305 O GLY A 310 SHEET 4 AA1 4 VAL A 298 ASN A 299 -1 N ASN A 299 O GLY A 302 SHEET 1 AA2 4 PHE B 211 ILE B 213 0 SHEET 2 AA2 4 GLY B 310 THR B 313 1 O PHE B 311 N ILE B 213 SHEET 3 AA2 4 GLY B 302 VAL B 305 -1 N LEU B 303 O VAL B 312 SHEET 4 AA2 4 VAL B 298 ASN B 299 -1 N ASN B 299 O GLY B 302 CISPEP 1 LYS A 322 PRO A 323 0 2.75 CISPEP 2 LYS B 322 PRO B 323 0 6.20 CRYST1 39.166 94.948 96.932 90.00 97.78 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025532 0.000000 0.003488 0.00000 SCALE2 0.000000 0.010532 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010412 0.00000